Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection

ABSTRACT A flurry of recent reports on the role of activating and inhibitory forms of the killer cell immunoglobulin-like receptors (KIR) in natural killer (NK) cell activity against human immunodeficiency virus type 1 (HIV-1) have yielded widely divergent results. The role of the activating NK receptor encoded by the KIR3DS1 allele and its putative ligands, members of the HLA class I Bw4Ile80 cluster, in early HIV-1 disease is controversial. We selected 60 treatment-naïve adults for study from the OPTIONS cohort of individuals with early HIV-1 infection in San Francisco. We performed NK cell functional assays measuring gamma interferon (IFN-γ) and CD107a expression by NK cells in the unstimulated state and after stimulation by the major histocompatibility complex class I-deficient 721.221 B-lymphoblastoid cell line. In addition, we measured CD38 expression (a T-cell activation marker) on T and NK cells. Persons who have at least one copy of the KIR3DS1 gene had higher IFN-γ and CD107a expression in the unstimulated state compared to those who do not possess this gene. After stimulation, both groups experienced a large induction of IFN-γ and CD107a, with KIR3DS1 carriers achieving a greater amount of IFN-γ expression. Differences in effector activity correlating with KIR3DS1 were not attributable to joint carriage of HLA Bw4Ile80 and KIR3DS1. We detected a partial but not complete dependence of KIR3DS1 on the members of B*58 supertype (B*57 and B*58) leading to higher NK cell function. Possessing KIR3DS1 was associated with lower expression of CD38 on both CD8+ T and NK cells and with a loss or weakening of the known strong associations between CD8+ T-cell expression of CD38 mean fluorescence intensity and the HIV-1 viral load. We observed that possessing KIR3DS1 was associated with higher NK cell effector functions in early HIV-1 disease, despite the absence of HLA Bw4Ile80, a putative ligand of KIR3DS1. Carriage of KIR3DS1 was associated with diminished CD8+ T-cell activation, as determined by expression of CD38, and a disruption of the traditional relationship between viral load and activation in HIV-1 disease, which may lead to better clinical outcomes for these individuals.

[1]  Todd M. Allen,et al.  Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes , 2007, The Journal of experimental medicine.

[2]  M. Carrington,et al.  A mutation in KIR3DS1 that results in truncation and lack of cell surface expression , 2007, Immunogenetics.

[3]  M. Altfeld,et al.  Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection12 , 2007, The Journal of Immunology.

[4]  M. Altfeld,et al.  'Unleashed' natural killers hinder HIV , 2007, Nature Genetics.

[5]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[6]  M. Carrington,et al.  Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. , 2007, AIDS research and human retroviruses.

[7]  F. Hecht,et al.  Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression , 2007, PLoS pathogens.

[8]  D. Nixon,et al.  Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1 , 2007, The Journal of Immunology.

[9]  P. Parham,et al.  Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells1 , 2007, The Journal of Immunology.

[10]  B. Vuylsteke,et al.  Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands1 , 2006, The Journal of Immunology.

[11]  David R Bangsberg,et al.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. , 2006, JAMA.

[12]  J. Goedert,et al.  KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections , 2006, PLoS pathogens.

[13]  C. Chougnet,et al.  Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. , 2006, Clinical immunology.

[14]  Karnail Singh,et al.  Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. , 2006, Blood.

[15]  C. Moore,et al.  Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression , 2005, Genes and Immunity.

[16]  P. Parham,et al.  KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand1 , 2005, The Journal of Immunology.

[17]  F. Christiansen,et al.  Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses. , 2005, Molecular immunology.

[18]  P. Leibson,et al.  Stimulatory Killer Ig-Like Receptors Modulate T Cell Activation through DAP12-Dependent and DAP12-Independent Mechanisms1 , 2004, The Journal of Immunology.

[19]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[20]  M. Segal,et al.  Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. , 2004, The Journal of infectious diseases.

[21]  D. Scott‐Algara,et al.  Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users 1 , 2003, The Journal of Immunology.

[22]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[23]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[24]  F. Malavasi,et al.  CD38 triggers cytotoxic responses in activated human natural killer cells. , 1999, Blood.

[25]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[26]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[27]  S. Coppens,et al.  Interpatient genetic variability of HIV-1 group O. , 1999, AIDS.

[28]  R. Means,et al.  Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques , 1998, Journal of Virology.

[29]  R. Detels,et al.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[30]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[31]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[32]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[33]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.